Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

1 G3 skin Out of RT field Unlikely 2 G3 neuropathy Out of RT ... Began prior to RT Unlikely 9 G3 oral mucositis Out of RT field Unlikely 10 G5 neutropenia vs. pneumonitis 1 week after completing ...

Late-onset neutropenia (LON) is emerging as a common adverse effect to rituximab therapy owing to widespread use of this drug in the treatment of B-cell lymphomas and autoimmune diseases.